Related Experiment Video
Updated: Jun 13, 2026

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
Published on: December 16, 2022
Human mannose receptor (CD206) in immune response: novel insights into vaccination strategies using a humanized mouse
Suryasarathi Dasgupta1, Jagadeesh Bayry, Sebastien Lacroix-Desmazes
1Unité 872, Institut National de la Santé et de la Recherche Médicale, F-75006 Paris, France. surya.dasgupta@crc.jussieu.fr
Abstract:
Evaluation of: He LZ, Crocker A, Lee J et al. Antigenic targeting of the human mannose receptor induces tumor immunity. J. Immunol. 178(10), 6259-6267 (2007). Induction of adaptive immune response requires, in most cases, internalization of the antigen by professional antigen-presenting cells. Various endocytic receptors may mediate such interaction. However, little is known regarding the exact participation of such receptors in the context of immune response in vivo. This paper evaluates a recent work that utilizes one such molecule, the human CD206, transgenically incorporated into mouse, in order to establish its role in immune response. Such a study benefits from the fact that the function of the human form of the receptor is elaborated and thus would help to define new targets for future vaccine strategies.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Human Virome
